STING1 and colorectal carcinoma: When comparing 5-year RFS and 10-year OS among patients with cGAS+/STING+, cGAS+/STING−-, cGAS−/STING+, and cGAS−/STING− pMMR CRCs, patients with cGAS+/STING+ pMMR CRCs exhibited a tendency to have better 5-year RFS, but not 10-year OS, compared to the other three groups of patients with pMMR CRC (Figure 4E and Figure S8D).